Global Product Portfolio

Below is a list of the treatments we currently offer via our Innovative Medicines Division. Visit Sandoz and Advanced Accelerator Applications to learn about our generics and radiopharmaceutical products.
Please note: Not all treatments are available in all countries.

A B C D E F G I J K L M N O P R S T U V X Z

Respiratory

Seebri Breezhaler®

glycopyrronium bromide
Respiratory
Respiratory
Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Japan

Ophthalmology

Simbrinza®

brinzolamide, brimonidine tartrate
Ophthalmology
Ophthalmology
Global Product Site USA Germany Australia Austria Poland Netherlands Canada

Systane®

polyethylene glycol 400, propylene glycol
Ophthalmology
Ophthalmology
Global Product Site

Systane® Balance

propylene glycol
Ophthalmology
Ophthalmology
Global Product Site

Systane® Hydration

polyethylene glycol 400, propylene glycol, hyaluronic acid
Ophthalmology
Ophthalmology
Global Product Site

Systane® Ultra

polyethylene glycol 400, propylene glycol
Ophthalmology
Ophthalmology
Global Product Site

Oncology

Sandostatin LAR®

octreotide acetate
Oncology
Oncology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Poland Netherlands Canada Turkey Japan

Sandostatin® SC

octreotide acetate
Oncology
Oncology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Poland Netherlands Canada Turkey Japan

Immunology and Dermatology

Simulect®

basiliximab
Immunology and Dermatology
Immunology and Dermatology
Global Product Site USA Finland Germany United Kingdom Austria Poland Netherlands Canada Turkey

Established Medicines

Stalevo®

carbidopa, levodopa, entacapone
Neuroscience
Established Medicines
Global Product Site USA Australia Austria Netherlands Canada Turkey Japan